IntegraGen announces the company’s MERCURY™ cloud-based analytical software tool has achieved Conformité Européenne (CE) marking. This registration enhances the ability for IntegraGen sell MERCURY throughout the European Union (EU). MERCURY is utilized by researchers and clinicians to assist with the analysis of sequencing data derived from small and large gene sequencing panels as well as whole exome, RNA-Seq and whole genome sequencing.
CE-IVD marking of MERCURY indicates that it meets the provisions of the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Click here to view MERCURY’s CE Declaration of Conformity certificate.
The cloud-based platform utilized by MERCURY also regularly undergoes independent veriﬁcation of security, privacy, and compliance controls, achieving certiﬁcations in line with global standards. Learn more about how IntegraGen ensures the security and privacy of genomic data.